title: Switching to darunavir/ritonavir achieves viral suppression in patients with persistent low replication on first-line lopinavir/ritonavir.
authors.forename: Marie-Laure
authors.initials: ML
authors.lastname: Chaix
authors.forename: Sabrinel
authors.initials: S
authors.lastname: Sahali
authors.forename: Coralie
authors.initials: C
authors.lastname: Pallier
authors.forename: Aurélie
authors.initials: A
authors.lastname: Barrail-Tran
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Delfraissy
authors.forename: Jade
authors.initials: J
authors.lastname: Ghosn
mesh_terms: D000069454:Darunavir; D004347:Drug Interactions; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones; D019438:Ritonavir; D013449:Sulfonamides; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D013449:Sulfonamides; D061466:Lopinavir; D019438:Ritonavir; D000069454:Darunavir